Sikaote Acetyllevocarnitine Hydrochloride Tablets

1. Indications and Usage
Diabetic Peripheral Neuropathy: Indicated for the improvement of neurological symptoms (such as pain, numbness, and paresthesia) associated with diabetic polyneuropathy.
Neurocognitive Disorders: Used for the treatment of cognitive impairment in the elderly, including age-related memory loss and dementia.
2. Dosage and Administration
Standard Dose: The usual dosage is 500–1500 mg daily, divided into 2–3 doses.
Administration: Taken orally. The dose may be adjusted based on the patient’s condition and response.
Duration: Treatment duration should be determined by the physician based on clinical improvement.
3. Mechanism of Action
Mitochondrial Function: It acts as a cofactor in the mitochondrial oxidation of fatty acids, enhancing cellular energy metabolism.
Neurotransmitter Synthesis: It promotes the synthesis and modulation of acetylcholine, a neurotransmitter critical for memory and cognitive function.
Neuroprotection: It helps protect neurons from oxidative stress and supports nerve regeneration.
4. Safety and Warnings
Hypersensitivity: Contraindicated in patients with known hypersensitivity to acetyllevocarnitine, other carnitines, or any excipients.
Thyroid Disorders: Use with caution in patients with hypothyroidism, as it may interfere with thyroid hormone metabolism.
Renal/Hepatic Impairment: Dose adjustment may be necessary in patients with severe renal or hepatic dysfunction.
5. Adverse Reactions and Clinical Research
Common Adverse Reactions: Gastrointestinal disturbances (nausea, diarrhea), headache, dizziness, and insomnia.
Rare Effects: Skin rash, pruritus, and metallic taste in the mouth.
Clinical Findings: Clinical trials have demonstrated significant improvement in neuropathic symptom scores and cognitive function tests.
6. Drug Interactions
Warfarin: Acetyllevocarnitine may potentiate the anticoagulant effect of warfarin, increasing the risk of bleeding.
Thyroid Hormones: May enhance the effects of levothyroxine.
Antiepileptics: Theoretical interactions with antiepileptic drugs, though clinical significance is low.
7. Pharmaceutical Information
Active Ingredient: Acetyllevocarnitine Hydrochloride.
Strengths: Typically available as 250 mg or 500 mg tablets.
Appearance: White or off-white tablets.
Storage: Store in a cool, dry place, protected from light and moisture.